Oruka Therapeutics Inc (ORKA)
$96.87 +0.23% Close Oct 30, 2026 Live
Oruka Therapeutics stock today
Oruka Therapeutics closed at $96.87 on October 30, 2026, up 0.23% on the day. Over the past year it returned +244.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $5.84 billion.
$50.00$100.00
NovJan 2026MarMayJulSep
| Period | ORKA | S&P 500 (SPY) |
|---|---|---|
| 1 month | +16.3% | -0.9% |
| 3 months | -1.0% | +2.1% |
| Year to date | +219.6% | +11.7% |
| 1 year | +244.6% | +12.4% |
| 3 years | +637.8% | +88.5% |
| 5 years | +384.7% | +76.0% |
Key statistics
- Market value
- $5.84B
- 52-week range
- $26.19 to $113.08
- Next report
- Nov 11, 2026 (estimated)
About Oruka Therapeutics
Biopharmaceutical company developing therapies for eye diseases.
Sector: Health Care
More on Oruka Therapeutics
- Returns: what $1,000 became$1,000 ten years ago is $335.38 today
No forecast, no recommendation. This page describes Oruka Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.